Thermal ablation of hepatocellular carcinoma

Cancer Imaging

Volumn 8, Issue 1, 2008, Pages 19-26

  Crocetti, Laura ^a,b   Lencioni, Riccardo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Ablation; Hepatocellular carcinoma; Radiofrequency

Indexed keywords

ALCOHOL; BILIRUBIN;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CHRONIC LIVER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; HEPATITIS B; HEPATITIS C; HUMAN; LASER SURGERY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; LIVER TRANSPLANTATION; MICROWAVE IRRADIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; RADIOFREQUENCY ABLATION; THERMAL ABLATION; CATHETER ABLATION; HEAT; HOSPITALIZATION; LIVER TUMOR; LOW LEVEL LASER THERAPY; METHODOLOGY; MICROWAVE RADIATION; MORTALITY; PATHOLOGY; REVIEW; SURVIVAL; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; ETHANOL; HEAT; HUMANS; LASER THERAPY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MICROWAVES; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41149144171     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2008.0004     Document Type: Article

References (68)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17.
2. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 2005; 25: 143-54.
3. Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell 2004; 5: 15-219.
4. Bruix J, Sherman M, Llovet JM et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-30.
5. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
6. Lencioni R, Cioni D, Della Pina C et al. Imaging diagnosis. Semin Liver Dis 2005; 25: 162-70.
7. Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 2005; 25: 133-42.
8. Levy I, Greig PD, Gallinger S et al. Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg 2001; 234: 206-9.
9. Johnson PJ. Hepatocellular carcinoma: is current therapy really altering outcome? Gut 2002; 51: 459-62.
10. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.
11. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
12. Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-55.
13. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-40.
14. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790-800.
15. Wayne JD, Lauwers GY, Ikai I et al. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 2002; 235: 722-731.
16. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25: 181-200.
17. Jonas S, Beckstein WO, Steinmuller T et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-6.
18. Yao FY, Ferrel L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: expansion of tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403.
19. Yao FY, Bass NM, Nikolai B et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002; 8: 873-83.
20. Lencioni R, Bartolozzi C, Caramella D et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer 1995; 76: 1737-46.
21. Livraghi T, Giorgio A, Marin G et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-8.
22. Ryu M, Shimamura Y, Kinoshita T et al. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 1997; 27: 251-7.
23. Lencioni R, Pinto F, Armillotta N et al. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radio 1997; 7: 514-19.
24. Teratani T, Ishikawa T, Shiratori Y et al. Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy. Cancer 2002; 95: 816-23.
25. Ebara M, Okabe S, Kita K et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 2005; 43: 458-464.
26. Castells A, Bruix J, Bru C et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993; 18: 1121-6.
27. Yamamoto J, Okada S, Shimada K et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001; 34: 707-13.
28. Daniele B, De Sio I, Izzo F et al. CLIP Investigators. Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control study. J Clin Gastroenterol 2003; 36: 63-7.
29. Khan KN, Yatsuhashi H, Yamasaki K et al. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 2000; 32: 269-78.
30. Koda M, Murawaki Y, Mitsuda A et al. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000; 88: 529-37.
31. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancies: a unfied approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174: 323-31.
32. Dodd GD 3rd, Frank MS, Aribandi M et al. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol 2001; 177: 777-82.
33. Goldberg SN, Charboneau JW, Dodd 3rd GD et al. International Working Group on Image-Guided Tumor Ablation. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228: 335-45.
34. Lencioni R, Crocetti L. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis 2005; 9: 301-14.
35. Lu DS, Yu NC, Raman SS et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 2005; 234: 954-60.
36. Lencioni R, Allgaier HP, Cioni D et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-40.
37. Lin SM, Lin CJ, Lin CC et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 2004; 127: 1714-23.
38. Shiina S, Teratani T, Obi S et al. A randomized controlled trial of radiofrequency ablation versus ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-30.
39. Lencioni R, Cioni D, Crocetti L et al. Early-stage hepatocellular carcinoma in cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-7.
40. Tateishi F, Shiina S, Teratani T et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. Cancer 2005; 103: 1201-9.
41. Cabassa P, Donato F, Simeone F et al. Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes. AJR Am J Roentgenol 2006; 185: S316-21.
42. Choi D, Lim HK, Rhim H et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007; 17: 684-92.
43. Chen MS, Li JQ, Zheng Y et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321-8.
44. Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging 2005; 30: 409-18.
45. Livraghi T, Solbiati L, Meloni MF et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 26: 441-51.
46. De Baere T, Risse O, Kuoch V et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003; 181: 695-700.
47. Bleicher RJ, Allegra DP, Nora DT et al. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003; 10: 52-58.
48. Llovet JM, Vilana R, Bru C et al. Barcelona Clinic Liver Cancer (BCLC) Group. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33: 1124-9.
49. Fontana RJ, Hamidullah H, Nghiem H et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl 2002, 8: 1165-74.
50. Wong LL, Tanaka K, Lau L, Komura S. Pre-transplant treatment of hepatocellular carcinoma: assesment of tumor necrosis in explanted livers. Clin Transplant 2004; 18: 227-34.
51. Lencioni R, Cioni D, Crocetti L, Bartolozzi C. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. Liver Transpl 2004; 10: S91-7.
52. Lu DS, Yu NC, Raman SS et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005; 41: 1130-37.
53. Rossi S, Garbagnati F, Lencioni R et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217: 119-26.
54. Yamasaki T, Kurokawa F, Shirahashi H et al. Percutaneous radio-frequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequeucy ablation therapy. Cancer 2002; 95: 2353-60.
55. Kitamoto M, Imagawa M, Yamada H et al. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. AJR Am J Roentgenol 2003; 181: 997-1003.
56. Lencioni R, Della Pina C, Bartolozzi C. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma. Abdom Imaging 2005; 30: 401-8.
57. Veltri A, Moretto P, Doriguzzi A et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 2006; 16: 661-9.
58. Lu MD, Chen JW, Xie XY et al. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001; 221: 167-72.
59. Yamashiki N, Kato T, Bejarano PA et al. Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers. Am J Gastroenterol 2003; 98: 2052-9.
60. Yu NC, Lu DS, Raman SS et al. Hepatocellular carcinoma: microwave ablation with multiple straight and loop antenna clusters - pilot comparison with pathologic findings. Radiology 2006; 239: 269-75.
61. Seki T, Wakabayashi M, Nakagawa T et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 1999; 85: 1694-702.
62. Dong B, Liang P, Yu X et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol 2003; 180: 1547-41.
63. Liang P, Dong B, Yu X et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005; 235: 299-307.
64. Shibata T, Iimuro Y, Yamamoto Y et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223: 331-7.
65. Vogl TJ, Muller PK, Hammerstingl R et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: technique and prospective results. Radiology 1995; 196: 257-65.
66. Pacella CM, Bizzarri G, Magnolfi F et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology 2001; 221: 712-20.
67. Vogl TJ, Straub R, Eichler K et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2520 lesions). Radiology 2002; 225: 367-77.
68. Lencioni R,, Della Pina C, Crocetti L, Cioni D. Percutaneous ablation of hepatocellular carcinoma. Recent Results Cancer Res 2006; 167: 91-105.